RecruitingNot ApplicableNCT07506044

Dexmedetomidine as an Adjuvant During Dural Puncture Epidural

The Effect of Different Doses of Dexmedetomidine as an Adjuvant to Bupivacaine for Parturients Having Dural Puncture Epidural Technique to Elaborate Labor Pain

Sponsor

Menoufia University

Enrollment

140 participants

Start Date

Feb 1, 2026

Study Type

INTERVENTIONAL

Conditions

Total Dose of Bupivacaine Administered During Labor

Summary

The study aimed to determine the effects of using varied doses of DEX on the concentration of bupivacaine injected for epidural labor analgesia, and to assess the benefits of the dural puncture epidural.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Dexmedetomidine 0.4 added, a drug called Dexmedetomidine 0.6 added, and others for people with total dose of bupivacaine administered during labor. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 40 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEEpidural Catheter with bupivacaine

epidural injection of plain Bup

DEVICEEpidural with dural puncture

the dura is punctured by a 26-G spinal needle using the needle-through-needle technique, and is withdrawn after confirmation of free-flowing cerebrospinal fluid,

DRUGDexmedetomidine 0.4 added

Dexmedetomidine 0.4 added

DRUGDexmedetomidine 0.6 added

Dexmedetomidine 0.6 added

Locations(1)

Faculty of Medicine Menoufia University

Shebeen El Kom, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07506044